Researchers at The University of Pennsylvania College of Medicine in Hershey sought to determine the attributable costs and LOS associated with CLABSIs in the pediatric hematology and oncology population.
They examined 1,562 inpatient admissions for 291 pediatric patients between January 2008 and May 2011.
The study demonstrated the additional LOS related to a CLABSI in this population was 21.2 days, and increased costs of nearly $70,000.
They suggest their findings could help shape decisions about efforts to prevent CLABSIs for pediatric oncology patients.
More articles on HAIs:
10 most popular infection control stories for October
4 areas to focus on for improved hand hygiene
Topical antibiotics linked to increased pneumonia rates
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.